课题基金 / 基金详情

Discovery of a novel immune evasion strategy employed by mosquito borne viruses to suppress antiviral immune responses

Discovery of a novel immune evasion strategy employed by mosquito borne viruses to suppress antiviral immune responses
发现蚊媒病毒采用新型免疫逃避策略来抑制抗病毒免疫反应
批准号:
nhmrc : 399700
负责人:
Prof Andreas Suhrbier
金额:
$27.92万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2006
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2006-01-01 至 2008-12-31

项目摘要

项目成果

Prof Andreas Suhrbier的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The transition from mosquitoes, ticks, or other invertebrate vectors to the human hosts represents a crucial step in the successful establishment of arthropod borne viruses (arboviruses). The incidence of arbovirus infections such as dengue virus, West Nile virus, Ross River virus is increasing at an alarming rate in various parts of the world. In addition, the emergence of new viruses resulting in significant mortality in the population is of utmost concern. Vaccines for many of these viruses remain elusive. One factor that contributes to this is the ability of viruses to develop ingenious strategies to avoid or suppress the host defence systems, which enable its successful establishment in the host. Understanding how viruses evade-suppress host defence machinery will certainly enhance and improve our approaches to fight them. For the first time internationally we have discovered a new and novel pathway employed by arboviruses to suppress antiviral immune responses in the host. We have discovered that naturally occurring carbohydrates on viruses derived from mosquito cells, would influence these virus s ability to evade-suppress host antiviral proteins such as interferons. This may be a general effect of arboviruses or may even extend to other viruses , which include a number of deadly pathogens (HIV, Influenza). This research has the potential to significantly expand our understanding of how these viruses establish infection and cause disease. Also this discovery has broader implications for understanding inflammatory processes and their regulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving treatment strategies for chronic alphaviral arthritic diseases
  • 批准号:
    nhmrc : GNT1078468
  • 项目类别:
    Project Grants
  • 资助金额:
    $62.35万
  • 财政年份:
    2015
  • 负责人:
    Prof Andreas Suhrbier
  • 依托单位:
Improving treatment strategies for chronic alphaviral arthritic diseases
  • 批准号:
    nhmrc : 1078468
  • 项目类别:
    Project Grants
  • 资助金额:
    $42.92万
  • 财政年份:
    2015
  • 负责人:
    Prof Andreas Suhrbier
  • 依托单位:
Arbovirus activation and modulation of NLRP3 inflammasome
  • 批准号:
    nhmrc : 1079086
  • 项目类别:
    Project Grants
  • 资助金额:
    $51.99万
  • 财政年份:
    2015
  • 负责人:
    Prof Andreas Suhrbier
  • 依托单位:
Applied inflammation biology
  • 批准号:
    nhmrc : 1058391
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $55.91万
  • 财政年份:
    2014
  • 负责人:
    Prof Andreas Suhrbier
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: